-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A recent report by Transparency Market Research expects the global medical plastics market to grow substantially during 2019-2027, at a CAGR of
Production of complex thin-walled products from high-flow polycarbonate
Production of complex thin-walled products from high-flow polycarbonateIn the healthcare industry, the trend towards miniaturization is affecting the way products are design.
To address the challenges of device design, Covestro has developed Makrolon Rx2235 polycarbona.
Pierre Moulinié, Head of Global Medical Technology at Covestro's Polycarbonate Business Unit, points out that Makrolon Rx2235 polycarbonate sets new benchmarks in flow length and has the desired transparency and toughness of polycarbonate, helping manufacturers to fill Very thin-walled products, enabling precise reproduction of complex structures at lower pressur.
Makrolon Rx2235 polycarbonate is specially designed to meet the stringent requirements of the medical industry, is biocompatible (tested to ISO 10993-1 requirements), and can be sterilized using gamma or electron beam metho.
Makrolon 2258 polycarbonate is suitable for ETO and steam sterilization, is biocompatible (according to ISO 10993-1 testing requirements), and has a low viscosity for easy mold relea.
Makrolon Rx2235 polycarbonate is an important addition to Covestro's broad range of medical polycarbonat.
Economical Heart Valves Made of Thermoplastics
Economical Heart Valves Made of ThermoplasticsReducing healthcare costs and improving the overall quality of care has received a lot of attention over the past few years, and a lot of work has been done on th.
DSM (Royal DSM) and Strait Access Technologies (SAT) announced in May this year that they are collaborating to develop the first durable, economical transcatheter replacement heart valves with polymer leafle.
The breakthrough product developed by SAT and DSM will address the challenges of rheumatic heart disease in terms of biology, cost and ease of operati.
Currently, existing mechanical or animal tissue replacement valves are not suitable for rheumatic heart disease patients, who are usually young.
USDA Certified Sustainable Bioplastics
USDA Certified Sustainable BioplasticsIn the medical field, sustainable development is also one of the topics that cannot be ignor.
With this in mind, Eastman developed TRĒVA bioengineering plastics, designed to illustrate how companies address the balance between sustainability and performan.